Search

everythinglearnresearchcommunity

for

Search:↓

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Testosterone may influence COVID-19 severity and outcomes.

Testosterone's effects on COVID-19 are unclear and need more research.

Cepharanthine could be a strong antiviral against COVID-19.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Possible link between COVID-19 and hair loss; more research needed.

Long COVID causes various long-term health issues and needs better awareness and treatment.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Olive oil can help regrow hair lost due to COVID-19 or vaccination.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Women with high androgen levels may have more severe COVID-19 symptoms.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.